CVA Family Office, LLC
Family OfficePosition in GILD — Gilead Sciences, Inc.
CIK 1802084
DENVER, CO
Position in GILD
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$316,102
-$115,945 QoQ
Shares Held
2,502
-19.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,619
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. GILD ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,076 | $3,689,446 | |
| 2 | JNJ |
Johnson & Johnson
|
9,737 | $2,472,905 | |
| 3 | AMGN |
Amgen Inc
|
4,049 | $1,466,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,140 | $1,431,490 | |
| 5 | ABBV |
AbbVie Inc.
|
4,882 | $1,228,506 | |
| 6 | NVS |
Novartis AG
|
5,542 | $868,542 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,306 | $536,211 | |
| 8 | GSK |
GSK plc
|
8,000 | $419,360 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,102 | 2,502 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $432,047 | 3,100 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $293,839 | 2,394 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $265,179 | 2,389 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $269,524 | 2,431 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $263,541 | 2,352 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $214,575 | 2,323 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $131,041 | 1,563 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $96,465 | 1,406 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $115,808 | 1,581 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $146,871 | 1,813 | Shares | Sole | 2024-01-16 | |
| 2023-06-30 | $111,597 | 1,448 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $115,162 | 1,388 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $122,507 | 1,427 | Shares | Sole | 2023-02-22 | |
| 2022-09-30 | $82,787 | 1,342 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $53,589 | 867 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,307 | 22 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $75,223 | 1,036 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $85,217 | 1,220 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $77,192 | 1,121 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $56,615 | 876 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $30,353 | 521 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $77,091 | 1,220 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $86,172 | 1,120 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $14,952 | 200 | Shares | Sole | 2020-05-28 | |
| No filing history on record for this holder in this stock. | ||||||